No abstract

The purpose of this work is to demonstrate the reproductive efficacy and the economic impact of a complementary tool to the TAI (timed artificial insemination) protocols - the administration of a single dose of recombinant human galectin-1 (rHGAL1) during the insemination procedure. GAL-1 can be considered as a modulator of the pregnancy development process. Reproductive efficacy was verified through the pregnancy rate in the first service, by ultrasonography (at 28-35 days) in contemporary groups (YG) of cows subdivided into 02 experimental groups (Control Group, composed of cows inseminated in a conventional and Treated group, composed of cows inseminated with rHGAL-1 administration following the deposition of the semen dose). Ninety YG were formed, grouping cows under identical conditions (inseminator, farm/lot, breed, animal category, semen/bull variables). The experiment was conducted in 15 farms, with 3,125 cows (Nellore and crossbred), all multiparous and with calf at foot (from 60 to 100 days old) and who maintained a body score (BSC) between 3.5 and 2.5 in the act of the TAI protocol and in the pregnancy diagnosis. It was demonstrated, by the proposed statistical method, that the “rHGAl-1 dose” effect was significant, increasing the probability of obtaining pregnancy by 8.38 percentage points (p < 0.0001). Based on the construction of a hypothetical model, the economic profitability that can be obtained were compared. Using the average increase obtained by 8.38 percentage points more in the pregnancy rate, it was possible to increase productivity, adding, almost U$ 2 thousand to profitability for each 100 cows worked.

The objective was to evaluate the efficacy of a single dose of exogenous galectin-1 in improving the pregnancy rate in inseminated cows, comparing the pregnancy rate of the two groups (treatment and control Groups) into 107 contemporary groups (YG) established. An ultrasound exam determined the pregnancy rate performed 25 to 35 days after the fixed-time artificial insemination (FTAI) of breeding beef cows (n = 3469). The pregnancy rate of cows that received a single dose of eGAL-1 (200 ± 10 µg), with an intrauterine administration (n = 1901), was compared with the pregnancy rate of cows inseminated using a conventional AI protocol (n = 1568), both comparing into the same YG. YGs were created considering the grouping of cows belonging to the same farm, with the same nutritional score and management, inseminated by the same inseminator and semen batch, and using the same estrus synchronization protocol). The statistical method used calculated the probability of obtaining pregnancy within each group. The administration of a single dose of eGAL-1 can increase the probability of obtaining pregnancy in beef cows by up to 8.68% (p < 0.0001), suggesting that a single dose of eGAL-1 during the FTAI procedure was reasonable in the beef cattle AI routine and can improve the pregnancy rate considerably.

No abstract